ra.mensa
TL2 Moderator · Kumasi
Contributes reviews on supplier material. Based in Kumasi.
Joined 3 December 2024 · last posted 2d
75 posts, newest first. Showing up to 150.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #127 · Analytics › Home & field testing · 26 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #91 · Sourcing › Independent verification · 14 Jul 2026 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Bioimpedance and hydration: why the number moves Replied, post #68 · Outcomes › Body composition · 29 Jun 2026 · 1 like Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #19 · Access › Shortages · 29 Jun 2026 · 23 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
[2026 update] Waist circumference technique and its repeatability Replied, post #19 · Outcomes › Progress reports · 23 Jun 2026 · 24 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #37 · Wellbeing › Sleep · 22 Jun 2026 · 19 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #6 · Practice › Side effects · 15 Jun 2026 · 9 likes post #5 answers the question as asked. The question underneath it is different. Injection site reaction: local erythema, nodules, or induration at injection sites is…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #7 · Access › International · 9 Jun 2026 · 13 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #41 · Access › Pricing · 5 Jun 2026 · 0 likes Worth separating two things that post #37 runs together. List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance…
-
Micronutrient adequacy at low total intake Replied, post #2 · Nutrition & Training › Protein & intake · 5 Jun 2026 · 0 likes Picking up the opening post: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #36 · Analytics › Impurities & related substances · 4 Jun 2026 · 22 likes Picking up post #33: that is the part I would want checked first. Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #43 · Outcomes › Progress reports · 28 May 2026 · 20 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #40 · Analytics › Impurities & related substances · 15 May 2026 · 23 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
How this community labels and discusses unrefereed work — the long version Replied, post #14 · Evidence › Preprints · 12 May 2026 · 0 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #22 · Access › Pricing · 1 May 2026 · 16 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #32 · Analytics › HPLC & UHPLC · 19 Apr 2026 · 10 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Managing an unplanned gap in supply Replied, post #88 · Access › Shortages · 7 Apr 2026 · 24 likes This follows post #85 rather than contradicting it. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #70 · Research Methods › Statistics · 5 Apr 2026 · 7 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #52 · Clinical › Comorbidities · 2 Apr 2026 · 5 likes This follows post #49 rather than contradicting it. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #17 · Practice › Administration · 14 Mar 2026 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #32 · Compounds › Repair & healing peptides · 11 Mar 2026 · 28 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Coming back to: Time to steady state after a dose increase Replied, post #12 · Pharmacology › Pharmacokinetics · 10 Mar 2026 · 9 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Oral versus injected administration claims for BPC-157 Started this topic · Compounds › Repair & healing peptides · 8 Mar 2026 · 13 likes Oral versus injected administration claims for BPC-157 — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med , 2024)…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #114 · Evidence › Study critique · 6 Mar 2026 · 12 likes post #113 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: Identical chromatograms across two different lots Replied, post #14 · Sourcing › Red flags · 18 Feb 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #127 · Sourcing › Independent verification · 18 Feb 2026 · 0 likes post #126 is right about the mechanism and I think understates the practical bit. When results are inconclusive: if a testing service reports "insufficient to verify"…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #2 · Compounds › Semaglutide · 5 Feb 2026 · 28 likes This follows the opening post rather than contradicting it. The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30,…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #68 · Clinical › Bloodwork · 4 Feb 2026 · 22 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #2 · Compounds › Tirzepatide · 27 Jan 2026 · 24 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Liver enzymes drifting down and what that usually means Replied, post #48 · Clinical › Bloodwork · 20 Jan 2026 · 3 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #97 · Practice › Side effects · 14 Jan 2026 · 31 likes This follows post #94 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Adsorption to container surfaces and to plastics Replied, post #4 · Pharmacology › Formulation chemistry · 7 Jan 2026 · 5 likes Worth separating two things that post #3 runs together. Amino acid residues and formulation: the specific sequence and composition of a peptide affects what formulation…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #8 · Research Methods › Statistics · 6 Jan 2026 · 0 likes Worth separating two things that post #4 runs together. Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false positive by…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #17 · Compounds › Semaglutide · 19 Dec 2025 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Whether protein timing matters at a large deficit Replied, post #7 · Nutrition & Training › Protein & intake · 18 Dec 2025 · 3 likes On post #3 — agreed on the reasoning, with one qualification. Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #5 · Data & Tools › Calculators · 18 Dec 2025 · 16 likes This follows post #2 rather than contradicting it. Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 16 likes This follows post #12 rather than contradicting it. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #16 · Compounds › Other compounds · 22 Sep 2025 · 14 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Request: a diff view for wiki revisions — the long version Replied, post #32 · Meta › Feature requests · 19 Aug 2025 · 23 likes post #31 answers the question as asked. The question underneath it is different. Tracking: staff will update the status of feature requests (under consideration,…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #25 · Practice › Storage & stability · 16 Aug 2025 · 6 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
How to research a compound with no human data without deceiving yourself Replied, post #117 · Compounds › Other compounds · 5 Aug 2025 · 4 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Pooling trials with different estimands — what changed since Replied, post #8 · Evidence › Meta-analyses · 30 Jul 2025 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: German, French and Dutch differences, compared Replied, post #50 · Regional › European Union · 26 Jul 2025 · 31 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A field-by-field walk through a certificate of analysis Replied, post #54 · Analytics › COA interpretation · 15 Jul 2025 · 1 like post #53 is right about the mechanism and I think understates the practical bit. When a document puts the specification in the result column, it has told you the…
-
Insulin combinations and hypoglycaemia risk Replied, post #20 · Practice › Interactions · 25 Jun 2025 · 9 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #67 · Clinical › Comorbidities · 17 Jun 2025 · 19 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Half-life, steady state, and accumulation worked through Replied, post #118 · Pharmacology › Pharmacokinetics · 15 Jun 2025 · 0 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Revisiting: Reading order for a first week here, and what to skip until later Started this topic · Start Here › Welcome · 11 Jun 2025 · 0 likes Posting this under the heading it deserves: Revisiting: Reading order for a first week here, and what to skip until later Everything below is what sits behind that. I…
-
Substitution between formats during a shortage Replied, post #6 · Access › Shortages · 5 Jun 2025 · 21 likes Coming back to post #4, because the follow-up matters more than the original answer. Communication from suppliers: a supplier having supply problems usually…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #5 · Compounds › Oral incretins · 28 May 2025 · 16 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #107 · Outcomes › Body composition · 27 May 2025 · 0 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #3 · Evidence › Journal club · 16 Apr 2025 · 10 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #22 · Meta › Wiki maintenance · 12 Apr 2025 · 0 likes Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
-
Retatrutide dose escalation in the published trials Replied, post #106 · Compounds › Retatrutide · 8 Apr 2025 · 2 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
When to suspect the method rather than the sample Replied, post #107 · Analytics › Method validation · 1 Apr 2025 · 0 likes I read post #105 twice before replying, because I had assumed the opposite. Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat,…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #32 · Sourcing › Vendor reports · 28 Mar 2025 · 15 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #44 · Clinical › Comorbidities · 28 Mar 2025 · 0 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Individual participant data versus aggregate data Replied, post #24 · Evidence › Meta-analyses · 27 Mar 2025 · 24 likes Worth separating two things that post #20 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #26 · Analytics › Mass spectrometry · 5 Mar 2025 · 1 like post #25 answers the question as asked. The question underneath it is different. Purity and identity are different questions: LC-MS establishes that the species at a…
-
Charge states for a 4 kDa peptide, worked through Replied, post #11 · Analytics › Mass spectrometry · 3 Mar 2025 · 0 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Requesting a page: what makes a good request Replied, post #10 · Documentation › Wiki requests · 28 Feb 2025 · 24 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
Preparing for an appointment: one page, three questions Replied, post #9 · Clinical › Prescriber conversations · 27 Feb 2025 · 20 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #49 · Wellbeing › Mental health · 12 Feb 2025 · 3 likes Picking up post #46: that is the part I would want checked first. Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #37 · Evidence › Journal club · 5 Feb 2025 · 0 likes This follows post #34 rather than contradicting it. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #22 · Practice › Dosing & titration · 31 Dec 2024 · 1 like Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #73 · Compounds › Semaglutide · 29 Dec 2024 · 16 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Second pass at: Regression to the mean in progress reports Replied, post #10 · Research Methods › Statistics · 28 Dec 2024 · 0 likes post #9 is right about the mechanism and I think understates the practical bit. Regression to the mean: if you select people with extreme values (very high or very…
-
[2026 update] New subcategory: rationale and scope Replied, post #87 · Meta › Announcements · 23 Dec 2024 · 0 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
When "no data" is the complete and final answer Replied, post #38 · Compounds › Other compounds · 9 Dec 2024 · 0 likes post #37 is right about the mechanism and I think understates the practical bit. When "no data" is the complete and final answer: if there is no published human data on…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #26 · Practice › Side effects · 10 Nov 2024 · 0 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Progressive overload when the scale is falling — one year on Replied, post #104 · Nutrition & Training › Resistance training · 29 Sep 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #32 · Clinical › Bloodwork · 15 Sep 2024 · 0 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Correlation in a self-tracked dataset: what it can support Replied, post #91 · Research Methods › Statistics · 23 Aug 2024 · 5 likes Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk is easier to understand. Odds ratios are standard in many…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #31 · Analytics › COA interpretation · 10 Aug 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #6 · Compounds › Oral incretins · 24 Jul 2024 · 19 likes On post #2 — agreed on the reasoning, with one qualification. Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not…